By BURTON E. SOBEL, M.D., AND Circulation, Volume XLV, infarction in man, material to follow will concern those three enzymes primarily.
General Considerations
Meaningful interpretation of serum enzyme determinations should be based upon several considerations:
1. Elevated serum enzyme activity associated with disease is generally assumed to reflect activity of enzyme released from injured tissue. In most conditions, the same enzymes with which an injured organ is richly endowed are those exhibiting elevated activity in serum following organ injury. 2 4 The time course of depletion of enzyme activity from a damaged organ parallels the time course of increase of activity of the same enzyme in serum following the insult."' 12 Following experimental coronary artery occlusion, a significant although small myocardial arteriovenous difference of enzyme activity can be demonstrated.'3 On the other hand, peak elevation of serum enzyme activity may not correlate closely with the magnitude of tissue damage,14 and some enzymes, such as ICD, which decrease in ischemic myocardium and increase in coronary sinus blood following experimental coronary artery occlusion, may not increase concomitantly in serum. 15 These disparities are reconciled when the rate of disappearance of enzyme activity from serum, the rate of release of enzyme from ischemic *Abbreviations: SGOT = serum glutamic oxaloacetic transaminase; LDH = lactic dehydrogenase; CPK = creatine phosphokinase; ICD = isocitric dehydrogenase; GGT = gamma-glutamyl transpeptidase; SPK = serum pyruvate kinase; GAPDH = glyceraldehyde phosphate dehydrogenase; OCT = ornithinecarbamyl transferase; SGPT= serum pyruvic transaminase; and NADP = nicotinamide-adenine dinucleotide phosphate. 471 myocardium, the fraction of myocardial enzyme undergoing local denaturation, and the distribution of enzyme released from the heart in body fluids are taken into account. Thus, ICD activity is not substantially elevated in serum following experimental myocardial infarction because the enzyme's disappearance rate from the circulation is very rapid.1-Furthermore, when serial changes in serum CPK activity following experimental myocardial infarction are analyzed according to a model based on these considerations, the correlation between myocardial enzyme depletion and increased serum enzyme activity is close (r=0.96) over a wide range of infarct size. 12 2. The relative value of enzyme determinations in the diagnosis of a specific disease entity should be assessed on the basis of both specificity and sensitivity of the test. True positives (instances of a positive result in a patient with the disease), false positives (instances of a positive result in a patient without the disease), and false negatives (instances of a negative result in a patient with the disease) should be considered. An enzyme test is highly specific when the ratio of true positives to false positives is high. It is highly sensitive when the ratio of true positives to false negatives is high and the incidence of false negatives is low. Obviously, sampling time and frequency will influence the apparent specificity and sensitivity of the determination.
3. Enzyme determinations are assays of activity, not of amount or concentration of a specific protein in serum. Accordingly, the apparent activity may be influenced by the presence of inhibitors, cofactors, activators, or unusual amounts of substrate or product in the serum sample. 16 4. The nature of the assay procedure used may influence results profoundly. Since only initial velocity is a reflection of enzyme activity, kinetic assays are generally superior to assays based on a single determination of product concentration and less prone to error introduced by nonspecific chromogens in biologic material.
5.
Other factors related to sampling, stor- age, and laboratory technique may impair the validity of enzyme determinations. 6 . The normal range of activity of each serum enzyme must be defined under the assay conditions employed and is usually defined as the mean ± 2 SD of values from a control population.-' 4 When a skewed distribution is observed in control samples, "normality" may be defined with a log normal curve.'7 These definitions of normality mean that the value obtained in a sample from a normal individual will fall within the normal range 95% of the time. Stated in another way, abnormal values for serum enzyme activity will be obtained in 5% of normal individuals. Thus, an "abnormal" value does not necessarily imply that the patient from whom it was obtained harbors disease. SGOT elevation26 perhaps because both SGOT and the incidence of arrhythmia reflect the extent of myocardial injury.
Approximately 25% of patients treated with direct-current countershock (electrical cardioversion) may exhibit increased SGOT activity usually less than threefold above normal. Since SGPT and isoenzymes of LDH identified with liver are not elevated in such patients,27 and since OCT, an enzyme identified almost exclusively with liver, does not increase28 it appears that the SGOT rise is due to enzyme release from skeletal muscle. CPK elevations, commonly seen, are both more frequent and more marked than SGOT elevations in this setting. 28 Several other conditions, frequently of interest to the cardiologist, may be associated with elevated SGOT activity. Patients with disease of the biliary tract who receive intravenous or intramuscular narcotic injections may exhibit transient increases in SGOT activity.29 Usually, the time course of elevation is much shorter and the magnitude much less than that seen typically following myocardial infarction. Concomitantly increased alkaline phosphatase activity is a valuable confirmatory sign indicating that the enzyme elevation is related to cholestasis potentiated by narcotic administration rather than to myocardial damage.
Approximately 11% of females taking oral contraceptive medication exhibit increased SGOT, usually late in the menstrual cycle,3j' and SGOT may be increased in patients treated with clofibrate. SGOT and CPK increased in 8% of 60 patients treated with large doses of clofibrate, and elevated enzyme activity and an associated myalgia waxed and waned with drug administration or its discontinuance, respectively.31 False-positive SGOT elevations following erythromycin administration are a problem only when the colorimetric enzyme assay is employed.32
SGOT may increase following cardiac catheterization. In both adults and children, the magnitude of serum enzyme elevations appears to be related to the duration and extent of dissection required during the procedure.33 Contrary to SGOT and LDH, CPK activity usually remains normal in patients with neoplastic disease. However, X-ray therapy involving the heart consistently produced CPK elevations in serum. CPK did not increase in patients exposed to comparable amounts of radiation(2000-5000 rads within 5 weeks) confined to regions excluding the myocardium but including skeletal muscle. 45 Serum CPK does not generally increase in patients with uncomplicated congestive heart failure.17 It may increase with pericarditis;but elevations are rare and those that do occur are usually slight.17 46 In myocarditis increased CPK activity often parallels the underlying severity of the inflammatory process. '6' 17 CPK has been considered an effective discriminant in the differential diagnosis between acute myocardial infarction and acute pulmonary embolism. However Efforts directed toward detecting "heart" LDH isoenzymes by rapid chemical procedures rather than electrophoretic techniques exploit properties of the dominant LDH subunit seen in heart LDH isoenzymes including heat stability, susceptibility to inhibition by pyruvate, resistance to inhibition by urea, and affinity for alpha-hydroxybutyric acid as a substrate. Alpha-hydroxybutyric dehydrogenase (a-HBD) should not be viewed as a specific enzyme but rather as enzymatic activity residing in that fraction of LDH with high affinity for alpha-hydroxybutyric acid.
Electrophoretic analysis of LDH isoenzymes continues to provide a more-sensitive and specific diagnostic index compared to the chemical techniques. However, precautions required include assay of enzyme activity within the range of linearity of the staining procedure used and control of temperature throughout the supporting medium. The major difficulty with chemical methods is that specific isoenzymes are not identified. Apparent enzyme activity with the chemical methods depends on total LDH activity and total subunits of each type rather than the isoenzyme profile per se. Thus, chemical inhibition methods may fail when total LDH activity is high. Lack of agreement between results of "heart" LDH isoenzyme activity estimated by urea inhibition and that determined electrophoretically occurs in as many as 24% of samples, with frank contradiction in as many as 10%."10 Despite these qualifications, LDH fractionation by chemical techniques led to true-positive results in a combined total of 457 of 464 patients from several centers.'06 61, 62 Thus, results with chemical fractionation techniques are more specific and sensitive than total LDH determinations, while those obtained with isoenzyme separation by electrophoresis surpass both.
Circulation, Volume XLV, Activity of Serum Enzymes in Patients with Coronary Insufficiency Insufficient coronary blood flow may be associated with several clinical syndromes and pathologic consequences. Yet, elucidation of the relationships between each of these syndromes and changes in serum enzymes has been difficult. In order to examine these relationships, it is useful to consider four syndromes of apparently decreasing severity: (1) definite transmural myocardial infarction with evolution of Q waves; (2) prolonged chest pain due to myocardial ischemia and associated with transient S-T-segment and Twave changes; (3) prolonged chest pain due to ischemia but associated with no electrocardiographic changes; and (4) typical angina pectoris. Compilation of data from several studies indicates that 92, 58, 27, and 5% of patients in these four categories, respectively, exhibit elevated SGOT, CPK, LDH, and/or LDH1.4 7, 8, 10, 16, 17, 19, 46, 60, 61, [63] [64] [65] Several conclusions appear warranted. The incidence and extent of enzyme elevations vary widely in patients with insufficient coronary blood flow without transmural myocardial infarction, probably because criteria for patient classification vary. The incidence of increased serum enzyme activity is greatest in patients with transmural myocardial infarction, decreases in those with chest pain and associated electrocardiographic changes, and is least in those with prolonged chest pain or angina pectoris without any electrocardiographic changes. This trend is consistent with the possibility that prevalence of myocardial necrosis in these patient groups follows the same trend and that enzyme elevations reflect necrosis.
Enzyme elevations that do occur are modest in patients with insufficient coronary blood flow without transmural myocardial infarction.16' 19 Mortality following definite myocardial infarction parallels, in general, the magnitude of peak enzyme elevation acutely.66 Thus, available clinical data are consistent with the interpretation that serum enzyme elevations following myocardial isehemia are indicative of myocardial necrosis. 24 hours after coronary artery occlusion correlated closely with the extent of acute cellular injury in the same site measured independently with the use of epicardial electrocardiographic recordings.-" A method based solely on serial changes of serum CPK activity was then developed for quantitative assessment of infarct size in the conscious animal.12 CPK released from the infarct was determined solely on the basis of serial serum CPK measurements analyzed with a model accounting for the rate of CPK disappearance from serum, the rate of release of CPK from myocardium undergoing infarction, the fraction of myocardial CPK degraded locally in the heart, and the distribution space into which CPK is diluted following release into the circulation, all of which were determined independently. Infarct size calculated on the basis of observed changes in serum CPK activity was compared with infarct size determined directly by analysis of myocardial CPK depletion in 22 animals. The correlation wvas close in each case. Results from all experiments fit a regression line with narrow confidence limits and a correlation coefficient of 0.96.12 These findings are consistent with the bulk of earlier experimental work and clinical observations that support the hypothesis that elevation of serum enzyme activity following myocardial infarction is a reflection of enzyme release from myocardial cells undergoing necrosis. Thus, although the relationship between changes in serum enzyme activity and infarct size is complex it appears to be quantitative. Accordingly, analysis of changes in serum enzyme activity following myocardial infarction should permit the accurate assessment of the extent of myocardial necrosis and its progression, so that the potent surgical tools becoming available for the patient with coronary artery disease can be focused effectively. 44, 1971 Circulation, Volume XLV, 
